Michael V. Milburn

2.6k total citations · 1 hit paper
10 papers, 2.1k citations indexed

About

Michael V. Milburn is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Michael V. Milburn has authored 10 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Michael V. Milburn's work include Cancer-related Molecular Pathways (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Michael V. Milburn is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Michael V. Milburn collaborates with scholars based in United States, Netherlands and Italy. Michael V. Milburn's co-authors include Millard H. Lambert, Christopher K. Glass, Jeffery E. Cobb, Timothy M. Willson, Robert T. Nolte, Stefan Westin, Riki Kurokawa, Michael G. Rosenfeld, G. Bruce Wisely and Anne M. Hassell and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Michael V. Milburn

9 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ

1998 1.6k citations Robert T. Nolte, G. Bruce Wisely et al. Nature profile →

Peers

Countries citing papers authored by Michael V. Milburn

Since Specialization

Citations

This map shows the geographic impact of Michael V. Milburn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael V. Milburn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael V. Milburn more than expected).

Fields of papers citing papers by Michael V. Milburn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael V. Milburn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael V. Milburn. The network helps show where Michael V. Milburn may publish in the future.

Co-authorship network of co-authors of Michael V. Milburn

This figure shows the co-authorship network connecting the top 25 collaborators of Michael V. Milburn. A scholar is included among the top collaborators of Michael V. Milburn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael V. Milburn. Michael V. Milburn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2–Based Immunotherapies 2024 ·The Journal of Immunology ·(unknown), Joel R. Eisner, Yuelong Guo, Yoichiro Shibata, James M. Davison, (unknown), Carol Farhangfar, Farhang Farhangfar, Jill M. Mooney, Michael V. Milburn, Richard L. White, Asim Amin, Marcos E. Milla, David Foureau	2
2	Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer 2024 ·Clinical Cancer Research ·Joel R. Eisner, (unknown), Yoichiro Shibata, Gregory M. Mayhew, James M. Davison, (unknown), Kirk L. Pappan, Shibu Thomas, Spyros Triantos, Ademi Santiago-Walker, Mahadi Baig, Michael V. Milburn, (unknown), Tahlita C.M. Zuiverloon	2
3	Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study 2023 ·Clinical Cancer Research ·Joel R. Eisner, Gregory M. Mayhew, James M. Davison, (unknown), Yoichiro Shibata, Yuelong Guo, Carol Farhangfar, Farhang Farhangfar, Joshua M. Uronis, Jeffrey M. Conroy, Michael V. Milburn, D. Neil Hayes, Kathryn F. Mileham	0
4	Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer 2022 ·Cancer Research Communications ·Joel R. Eisner, (unknown), Gregory M. Mayhew, Yoichiro Shibata, Yuelong Guo, Carol Farhangfar, Farhang Farhangfar, Joshua M. Uronis, Jill M. Mooney, Michael V. Milburn, David Foureau, Richard L. White, Asim Amin, Marcos E. Milla	1
5	Identification of novel insulin resistance metabolites in a non-diabetic population by global biochemical profiling 2009 ·Canadian Journal of Diabetes ·Ele Ferrannini, Walter Gall, Monica Nannipieri, Matteo Anselmino, Mônica Lanzoni Rossi, Kirk Beebe, (unknown), John Ryals, Michael V. Milburn	1
6	Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ breakdown → 1998 ·Nature ·Robert T. Nolte, G. Bruce Wisely, Stefan Westin, Jeffery E. Cobb, Millard H. Lambert, Riki Kurokawa, Michael G. Rosenfeld, Timothy M. Willson, Christopher K. Glass, Michael V. Milburn	1650
7	A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5 1993 ·Nature ·Michael V. Milburn, Anne M. Hassell, Millard H. Lambert, Steven R. Jordan, Amanda E. I. Proudfoot, Pierre Graber, Timothy N. C. Wells	201
8	Crystallization and Preliminary X-ray Diffraction Studies of Recombinant Human Interleukin-5 1993 ·Journal of Molecular Biology ·Anne M. Hassell, Timothy N. C. Wells, Pierre Graber, Amanda E. I. Proudfoot, Robert J. Anderegg, William Burkhart, Steven R. Jordan, Michael V. Milburn	8
9	X-ray crystal structures of transforming p21 ras mutants suggest a transition-state stabilization mechanism for GTP hydrolysis. 1992 ·Proceedings of the National Academy of Sciences ·Gilbert G. Privé, Michael V. Milburn, Liang Tong, Abraham M. de Vos, Ziro Yamaizumi, Susumu Nishimura, S H Kim	106
10	Structural differences between a ras oncogene protein and the normal protein 1989 ·Nature ·Liang Tong, Abraham M. de Vos, Michael V. Milburn, Jarmila Jancarik, Shigeru Noguchi, Susumu Nishimura, Kazunobu Miura, Eiko Ohtsuka, Sung‐Hou Kim	104

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact